Cite
HARVARD Citation
Ng, A. et al. (2022). Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel. Stroke and vascular neurology. 7 (4), pp. 310-318. [Online].